Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.

Tal Arnon and Irina Udalova

Tal Arnon will study the role of resident memory B (BRM) cells in protecting the lungs infected with the influenza virus.

The MRC grant will enable the Arnon Lab to further understand how pre-existing antibodies provide immunity against influenza, which is a major threat to human health that causes over 500,000 deaths per year globally.  Tal’s lab has already led a pioneering study exploring the dynamic behaviour of a unique subset of memory B cells that develop within the lungs following infection with the influenza virus. The research can now continue to discover how these cells differentiate into antibody producing cells and their role in establising short- and long-term immunity against influenza virus.

Speaking about the funding Tal said: “We are very excited to receive this funding and to further explore the role of resident memory B cells in protecting against the flu virus. Understanding the molecular mechanisms that regulate this process will help to guide the development of new and more effective vaccine strategies to prevent the spread of influenza variants.” 

Irina Udalova’s MRC grant will enable the study of the mechanisms contributing to inflammatory bowel diseases (IBD) such as such as Crohn's disease (CD) and Ulcerative Colitis, which are estimated to affect 1 in every 100 people in the UK. Irina’s recent work decoded molecular wiring of innate immune cells, called neutrophils, and identified key control hubs amendable to tailored therapeutic targeting. “However, the specific role of neutrophils during colitis remains largely unexplored,” said Irina. The team will now be asking what role neutrophils play in the initiation of intestinal inflammation that leads to IBD.

Using cutting-edge imaging technology, single cell genomic approaches and unique tools modulating neutrophil activity in vitro and in vivo models, the team will examine the functional impact of controlled modulation of neutrophil activity on the intestinal inflammation. Irina hopes the project will lead to the development of a new class of therapeutic strategies, based on selective modulation of neutrophil biology. “This MRC award will allow us to build our knowledge of their role in disease and offers hope for future treatments of the condition,” said Irina.

 

Similar stories

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Wellcome Trust Investigator Award for Professor Arnon

Congratulations to Professor Arnon on her successful Wellcome Trust Investigator Award entitled: “Spatiotemporal basis of adaptive immunity in the spleen.”

New research suggests targeting blood vessels could be key to controlling fibrotic disease

By studying blood vessels at single cell resolution, Professor Jagdeep Nanchahal and colleagues found that in Dupuytren’s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.

Defining the role of resident memory B cells in the fight against influenza

Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

The COVID-19 Multi-omic Blood Atlas (COMBAT) has identified blood hallmarks of COVID-19 involving particular immune cell populations and their development, components of innate and adaptive immunity, and connectivity with the inflammatory response.